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Sphingosine kinase 2 deficiency increases 
proliferation and migration of renal mouse 
mesangial cells and fibroblasts
Abstract: Both of the sphingosine kinase (SK) subtypes 
SK-1 and SK-2 catalyze the production of the bioactive lipid 
molecule sphingosine 1-phosphate (S1P).  However, the 
subtype-specific cellular functions are largely unknown. 
In this study, we investigated the cellular function of 
SK-2 in primary mouse renal mesangial cells (mMC) and 
embryonic fibroblasts (MEF) from wild-type C57BL/6 or 
SK-2 knockout (SK2ko) mice. We found that SK2ko cells 
displayed a significantly higher proliferative and migra-
tory activity when compared to wild-type cells, with 
concomitant increased cellular activities of the classical 
extracellular signal regulated kinase (ERK) and PI3K/Akt 
cascades, and of the small G protein RhoA. Furthermore, 
we detected an upregulation of SK-1 protein and S1P3 
receptor mRNA expression in SK-2ko cells. The MEK inhib-
itor U0126 and the S1P1/3 receptor antagonist VPC23019 
blocked the increased migration of SK-2ko cells. Addi-
tionally, S1P3ko mesangial cells showed a reduced pro-
liferative behavior and reduced migration rate upon S1P 
stimulation, suggesting a crucial involvement of the S1P3 
receptor. In summary, our data demonstrate that SK-2 
exerts suppressive effects on cell growth and migration 
in renal mesangial cells and fibroblasts, and that thera-
peutic targeting of SKs for treating proliferative diseases 
requires subtype-selective inhibitors.
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Introduction
One major function of sphingolipids is the structural 
support of cellular membranes. However, it has become 
clear that some sphingolipid subspecies also exert 
important signaling functions and thereby regulate a 
variety of physiological and pathophysiological pro-
cesses including cell growth and differentiation, cell sur-
vival, migration and inflammation (Huwiler et al., 2000; 
French et  al., 2003; Huwiler and Pfeilschifter, 2006; 
Kunkel et al., 2013).
In particular, ceramide and sphingosine 1-phosphate 
(S1P) have attracted a lot of interest, as they build a cellu-
lar rheostat that finally determines whether a cell grows or 
dies (Huwiler et al., 2000; Huwiler and Pfeilschifter, 2006; 
Kunkel et al., 2013). These two lipids are rapidly intercon-
verted by the action of two enzyme classes, i.e., the ceram-
idases that deacylate ceramide to form sphingosine, and 
sphingosine kinases (SK) that phosphorylate sphingosine 
to form S1P.
So far, two subtypes of, SK, SK-1 and SK-2, have been 
cloned and characterized (Alemany et  al., 2007). Both 
subtypes of SK are ubiquitously expressed in most tissues, 
but show differential subcellular localizations (Alemany 
et  al., 2007). Although both enzymes catalyze the same 
reaction and produce S1P, the physiological or pathophys-
iological functions of the two subtypes and variants are 
presently still unclear. Many studies have addressed the 
functions of SK-1 and there is a broad consent on its key 
function in cell proliferation and migration (Shida et al., 
2008; Pyne and Pyne, 2010). This is further supported by 
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studies showing an upregulation of SK-1 mRNA in several 
cancer types (French et  al., 2003, 2006; for review see 
Pyne and Pyne, 2010). Moreover, an increased SK-1 expres-
sion correlates with poor survival of breast cancer patients 
(Ruckhäberle et al., 2008).
In contrast, SK-2 has been appointed a rather pro-apo-
ptotic function based on cellular transfection experiments 
(Liu et al., 2003). SK-2 contains a BH3 domain that can inter-
act with Bcl-XL and thereby inhibit the protective potential of 
Bcl-XL consequently resulting in enhanced apoptosis. Addi-
tionally, the overexpression of SK-2 in various murine and 
human cell lines resulted in reduced DNA synthesis (Igarashi 
et al., 2003; Okada et al., 2005). In line with this, previous 
data on mouse mesangial cells isolated from SK-2 knockout 
mice revealed that lack of SK-2 protects from stress-induced 
apoptosis (Hofmann et al., 2008). However, recently it was 
suggested that also SK-2 positively contributes to cancer cell 
growth, as the putative selective SK-2 inhibitor ABC294640 
reduced cancer cell growth in vitro and in a tumor xeno-
graft model in mice (French et al., 2010).
In the present study, we used mouse renal mesangial 
cells (mMC) and mouse embryonic fibroblasts (MEF) iso-
lated from SK-2 deficient mice or siRNA against SK-2, and 
investigated changes in cellular responses such as cell 
migration and proliferation. We show that the loss of SK-2 
correlates with a higher proliferative and migratory phe-
notype of the cells. Conversely, when using the putative 
SK-2 inhibitor ABC294640, a reduced proliferation rate of 
renal mesangial cells was seen, which, surprisingly, was 
also detected in SK-2ko cells, suggesting that this com-
pound is non-specific and affects cell proliferation unre-
lated to SK-2 inhibition. On the molecular level, we found 
that SK-2 depleted cells have a compensatory upregulated 
SK-1 protein expression, an increased activity of the small 
G protein RhoA, increased activities of the classical ERK 
and PI3K/Akt cascades, and a strongly upregulated S1P3 
receptor expression. All these alterations may contribute 
to the observed increased cell migration and proliferation.
Results
Loss of SK-2 increases proliferation and 
migration of mouse mesangial cells and 
fibroblasts
As the cellular function of SK-2 is still poorly under-
stood, we used renal mesangial cells and MEF isolated 
from either wild-type mice or SK-2 gene deficient mice to 
unravel a possible contribution of SK-2 to physiological 
Figure 1: Sphingosine kinase 2 protein expression in mouse renal 
mesangial cells and embryonic fibroblasts.
Protein lysates of quiescent mouse mesangial cells (mMC) and 
mouse embryonic fibroblasts (MEF) isolated from either C57BL/6 
mice (Wt), SK-1 deficient mice (SK-1ko), SK-2 deficient mice (SK-2ko) 
or rat mesangial cells (rMC) were separated by SDS-PAGE, trans-
ferred to nitrocellulose and subjected to Western blot analysis 
using a specific antibody against mouse SK-2 at a dilution of 1:1000. 
Bands were visualized by the ECL method according to the manufac-
turer’s instructions.
or pathophysiological cell responses. First, renal mesan-
gial cells (Figure 1A) and MEF (Figure 1B) were character-
ized for SK-2 protein expression by Western blot analysis. 
SK-2 runs as an approximately 68 kDa band in SDS-PAGE. 
In primary cultures of mMCs or MEFs isolated from SK-2 
knockout (ko) mice, this band was abolished, confirm-
ing the complete knockout of the gene. The antibody 
additionally recognized a band at 43 kDa, which was not 
reduced in the SK-2 depleted cells, thus suggesting a likely 
unspecific staining.
Under normal cell culture conditions, it became 
obvious that SK-2ko cells proliferated much faster than the 
corresponding wild-type cells. To confirm that DNA synthe-
sis was enhanced, [3H]thymidine incorporation was meas-
ured in cells plated in equal numbers. As seen in Figure 
2A, over the time period of 2 days, SK-2ko mMC showed a 
several-fold increase of DNA synthesis. A similar increase 
was also seen in SK-2ko MEFs when compared to the wild-
type cells (Figure 2B) and in mesangial cells transiently 
transfected with siRNA against SK-2 (Figure 2C). Addition-
ally, we tested the putative SK-2 inhibitor ABC294640 on 
renal mesangial cell proliferation and detected a reduc-
tion of cell proliferation at a concentration of 30 μm and 
even more pronounced at 100 μm. Strikingly, the same 
effect was obtained when using SK-2 knockout mesangial 
cells (Figure 2D, grey bars) suggesting an unspecific effect 
of ABC294640 not related to SK-2 inhibition.
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In a next step, the migratory capacity of cells was 
determined. To this end, either an adapted Boyden 
chamber assay (Figure 3A) or a scratch assay (Figure 3B–G) 
was performed. In the adapted Boyden chamber assay, 
equal numbers of cells were plated onto a Transwell filter 
with 8 μm pores and allowed to migrate through the filter 
for 7 h. Thereafter, non-migrated cells were scraped away 
from the surface of the filter and cells that had migrated 
into the filter were visualized by DAPI staining. Figure 3A 
shows again that SK-2ko cells migrated faster than wild-
type cells. Another method to measure cell migration is 
the so-called scratch assay. However, this assay cannot 
discriminate between migrating cells and proliferating 
cells and results reflect more a mixture of migration and 
proliferation. Therefore, to minimize the amount of cell 
proliferation, we performed this assay under strongly 
reduced serum concentrations [1% fetal bovine serum 
(FBS)]. Again, our data reveal that SK-2ko mesangial cells 
(Figure 3B, right panels) and SK-2ko MEFs (Figure 3D, 
right panels) or cells transfected with siRNA against SK-2 
(Figure 3F, right panels) migrated faster than the corre-
sponding wild-type (Figure 3B and D, left panels) or non-
target siRNA transfected cells (Figure 3F, left panels).
Loss of SK-2 activates ERK and Akt signaling 
in mesangial cells and fibroblasts
We further investigated whether the increased prolif-
eration and migration of SK-2ko cells was the result of 
specifically activated signaling cascades, such as the 
well-known proliferation and migration regulating clas-
sical mitogen-activated protein kinase (MAPK)/ERK 
cascade. To this end, Western blot analyses of mesangial 
cell lysates were performed by staining for phosphoryl-
ated and thus activated p44-ERK1 and p42-ERK2. Quies-
cent wild-type cells that were incubated for 6 h in a very 
low serum concentration (1% FBS) expressed low levels of 
phospho-ERK1/2, whereas the SK-2ko cells showed a sig-
nificantly increased ERK1/2 phosphorylation (Figure 4A). 
Another signaling cascade that has been linked to cell 
growth and survival, but also to cell migration, is the 
PI3K/Akt cascade (Vivanco and Sawyers, 2002). We found 
that also phospho-Akt was enhanced in SK-2ko mesangial 
cells (Figure 4B), and similar data were obtained in MEFs 
(Figure 4C and D). All these data suggest that in SK-2ko 
cells the classical MAPK/ERK and the PI3K/Akt cascades 
are hyperactivated.
Figure 2: Effect of SK-2 deficiency on proliferation of mouse mesangial cells and embryonic fibroblasts.
104 mouse mesangial cells (A, C, D, mMC) or mouse embryonic fibroblasts (B, MEF) isolated from either wild-type C57BL/6 mice (Wt, open 
circles) or SK-2 deficient mice (SK-2ko, closed circles) or mesangial cells transiently transfected with a non-target siRNA (C, NT-siRNA, open 
circles) or siRNA against SK-2 (C, siSK-2, closed circles) were plated and grown for the indicated time periods in growth medium supple-
mented with [3H]thymidine alone (A–C) or with the indicated concentrations of ABC294640 for 24 h (D) and processed as described in the 
Methods section. [3H]thymidine incorporated into DNA was measured in a β-counter. Data are expressed as cpm/well (A, B) or % of control 
(C, D) and are mean±SD (n = 3–5). *p < 0.05, **p < 0.01, ***p < 0.001 considered statistically significant compared to the corresponding Wt 
values (A, B) or to the respective control values (C, D).
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Figure 3: Effect of SK-2 deficiency on migration of mouse mesangial cells and embryonic fibroblasts.
(A) 105 serum-starved mouse mesangial cells (open columns) or mouse embryonic fibroblasts (closed columns) isolated from either 
wild-type (Wt) or SK-2 deficient mice (SK-2ko) were subcultured onto Transwell filters and allowed to migrate for 7 h. Migrated cells were 
determined as described in the Methods section. (B–G) Quiescent wild-type (Wt) or SK-2 deficient (SK-2ko) mesangial cells (B, C, mMC), 
quiescent mouse embryonic fibroblasts (D, E, MEF) or transiently transfected mouse mesangial cells with either non-target siRNA (F, G, 
NT-siRNA) or siRNA against SK-2 (F, G, siSK-2) were subjected to a scratch and then allowed to recover for 24 h in DMEM containing 1% FBS. 
Light microscopy pictures were taken at time point 0 h and 24 h after the scratch (B, D, F show representative samples). Data in C, E, G show 
the quantification of the scratch area after 24 h and are expressed as invaded area from time point 0 h to 24 h as % of the Wt or NT-siRNA 
control and are mean±SD (n = 6–9). ***p < 0.001 is considered statistically significant compared to the Wt or the NT-siRNA control.
To see whether the ERK and PI3K/Akt pathways, are 
involved in the increased migration and proliferation seen 
in Sk-2ko cells, we performed scratch assays and measured 
DNA synthesis of mouse mesangial cells in the absence 
or presence of inhibitors of these signaling pathways. 
Figure  5A and B shows that the specific MEK inhibitor 
U0126 (Wymann et al., 1996; Favata et al., 1998), but not 
the PI3K inhibitor wortmannin (Wymann et  al., 1996) 
inhibited migration and proliferation of SK-2ko mMC.
Furthermore, it is well-known that small G proteins 
are important molecular regulators of cell migration and 
also proliferation (Hall, 1990). We therefore investigated 
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whether small G proteins are altered in SK-2ko cells. Small 
G protein activity was measured by G-LISA®, which spe-
cifically detect the activated forms of the indicated small 
G proteins (Keely et al., 2007). As shown in Figure 6, basal 
RhoA activity was significantly increased in SK-2ko mesan-
gial cells and this was further enhanced after S1P treat-
ment. In contrast, Ras, Rac and cdc42 were not altered in 
SK-2ko mesangial cells (data not shown).
Loss of SK-2 is associated with enhanced 
expression of SK-1 and the S1P3 receptor
In a next step, we tested both cell types for a possible 
compensatory upregulation of SK-1 expression. By using 
Western blot analysis, we indeed found an enhanced 
expression of SK-1 protein in SK-2ko mesangial cells 
and MEF. Even a partial and transient reduction of SK-2 
with SK-2-siRNA resulted in a higher SK-1 protein expres-
sion compared to non-target siRNA transfected cells 
(Figure  7A). Furthermore, we screened the cells for S1P 
receptor subtype expression and, interestingly, found that 
in SK-2ko mMCs (Figure 7B) and MEFs (Figure 7C) S1P3 
specifically was highly upregulated on the mRNA level. 
When using SK-2 siRNA, we also observed an increased 
mRNA expression of S1P3 in comparison to the control-
transfected cells (Figure 7D). In addition, we quanti-
fied cellular S1P in the cells and found that SK-2ko MEF 
contain significantly more cellular S1P than the wild-type 
cells (Figure 7F). Despite a similar upregulation of SK-1 
protein in SK-2ko mesangial cells, the S1P concentration 
in whole-cell lipid extracts of mMCs did not vary between 
wild-type and SK-2ko cells (Figure 7E). Sphingosine and 
C16-ceramide accumulated in SK-2ko cells in both cell 
types (Figure 7E and F). To address if the altered S1P 
receptor expression profile affected cell motility, we per-
formed a scratch migration assay in the presence of the 
S1P receptor antagonists W146 (S1P1 antagonist), JTE-013 
(S1P2 antagonist) and VPC23019 (S1P1/3 antagonist). Our 
data revealed that a significant reduction of cell migration 
was only detected in SK-2ko cells when using the S1P1/3 
inhibitor VPC23019, but not in the presence of W146, thus 
excluding a role of S1P1 in the increased migration capac-
ity of SK-2ko cells (Figure 8). The S1P2 inhibitor JTE-013 
enhanced the migratory response of wild-type and SK-2ko 
cells, thus demonstrating a potentially inhibitory role of 
S1P2 in mesangial cell migration (Figure 8). These data 
make it tempting to speculate that the observed enhanced 
Figure 4: Effect of SK-2 deficiency on the activation state of ERK1/2 and PKB/Akt in mouse mesangial cells and fibroblasts.
Quiescent mouse mesangial cells (A, B) and mouse embryonic fibroblasts (C, D) isolated from either wild-type (Wt, white bars) or SK-2 defi-
cient mice (SK-2ko, grey bars) were incubated for 6 h in DMEM containing 1% FBS. Thereafter, cell lysates containing 50 μg of protein were 
separated by SDS-PAGE, transferred to nitrocellulose and subjected to Western blot analysis using antibodies against phospho-ERK1/2 
and total ERK1/2 (A and C), and phospho-Ser473-PKB/Akt and total PKB/Akt1 (B, D). Bands were visualized by the ECL method according 
to the manufacturer’s instructions and bands were densitometrically evaluated. Data are expressed as % of controls and are mean±SD 
(n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 considered statistically significant compared to the corresponding Wt values. The insets show 
 representative immunoblots.
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Figure 5: Involvement of the PI3K and ERK pathway in the SK2ko-
mediated increased migration and proliferation in mesangial cells.
(A) Quiescent wild-type (Wt, white bar) or SK-2 deficient (SK-2ko, 
grey bars) mesangial cells (mMC) were subjected to a scratch and 
then allowed to recover for 24 h in DMEM containing 1% FBS in 
the absence (Ctrl) or presence of wortmannin (200 nm) or U0126 
(10 μm). Light microscopy pictures were taken at time point 0 h 
and 24 h after the scratch and analyzed using the Image J software 
(Wayne Rasband, NIH, USA) by measuring the scratch area. Data are 
expressed as area reduction from time points 0 h to 24 h as % of the 
Wt control and are mean±S.D. (n = 4). (B) Wild-type (Wt, white bars) 
or SK-2 deficient (SK-2ko, grey bars) mesangial cells (mMC) were 
plated and grown for the indicated time periods in growth medium 
supplemented with [3H]thymidine alone (Ctrl) or in the presence of 
wortmannin (200 nm) or U0126 (10 μm) and processed as described 
in the Methods section. [3H]thymidine incorporated into DNA was 
measured in a β-counter. Data are expressed as cpm/well and are 
mean±SD (n = 4–6). ***p < 0.001 considered statistically significant 
compared the Wt ctrl, §§§p < 0.001 considered statistically significant 
compared to the SK-2ko ctrl value.
Figure 6: Effect of SK-2 deficiency on RhoA activity in mouse 
mesangial cells.
Quiescent mouse mesangial cells isolated from either wild-type 
(Wt, white bars) or SK-2 deficient mice (SK-2ko, grey bars) were 
stimulated for 10 min with either vehicle (Ctrl) or sphingosine 
1-phosphate (S1P, 1 μm) in the presence of 1% FBS. Thereafter, cell 
lysates were subjected to G-LISA® RhoA activation assay according 
to the manufacturer’s instructions. Data are expressed % of Wt ctrl 
and are mean±SD (n = 3). **p < 0.01, ***p < 0.001 considered statisti-
cally significant compared to the vehicle treated Wt value, §§p < 0.01 
considered statistically significant compared to the S1P-stimulated 
Wt value.
migration and proliferation of SK-2ko cells was the result 
of an autocrine S1P action through the S1P3 receptor, 
although a further increase of S1P in renal mesangial cells 
seems dispensable.
Finally, we investigated the contribution of S1P3 to 
mesangial cell proliferation and migration by using cells 
isolated from S1P3 knockout mice. The data in Figure 9A 
show that the growth of S1P3ko mMCs in normal growth 
medium containing 10% FBS was only slightly but still 
significantly reduced when compared to wild-type cells. 
When migration of these cells was analyzed in a scratch 
assay, we found that stimulation with S1P triggered 
increased migration in wild-type cells (Figure 9B), which 
was abolished in S1P3ko cells (Figure 9B). In addition, 
the stimulation of RhoA activity by S1P detected in wild-
type cells was clearly reduced in S1P3ko cells (Figure 9C). 
Together, these data suggest that S1P3 indeed contributes 
to mesangial cell proliferation and migration.
Discussion
In this study we show for the first time that renal mesan-
gial cells and embryonic fibroblasts isolated from SK-2 
deficient mice have a higher capacity to proliferate and 
migrate when compared to wild-type cells. Since the suc-
cessful cloning of SK-2 in 2000 (Liu et al., 2000a), the few 
published studies have reported rather controversial data 
on possible cellular functions of SK-2.
On the one hand, overexpression studies in various 
cell types revealed that SK-2 is localized in the nucleus and 
can inhibit DNA synthesis (Igarashi et al., 2003). Moreover, 
Liu et al. (2003) reported that overexpression of SK-2 had 
a pro-apoptotic effect on cells because of the existence of 
a BH3 domain that interacts with the anti-apoptotic factor 
Bcl-XL and thereby blocks Bcl-XL’s anti-apoptotic function. 
In line with this, our own previous studies revealed that 
a loss of SK-2 rendered mesangial cells less sensitive to 
stress-induced apoptosis (Hofmann et al., 2008).
On the other hand, SK-2 was activated by epidermal 
growth factor (EGF) (Hait et al., 2007) due to ERK-mediated 
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Figure 7: Effect of SK-2 deficiency on SK-1 protein expression, S1P receptor subtype mRNA expression, and on cellular sphingolipid levels in 
mouse mesangial cells and embryonic fibroblasts.
(A) Quiescent mouse mesangial cells and mouse embryonic fibroblasts isolated from either C57BL/6 mice (Wt) or SK-2 deficient mice (SK-
2ko) or mouse mesangial cells transiently transfected with either non-target siRNA (NT-siRNA) or siRNA against SK-2 (siSK-2) were subjected 
to WB analysis using specific antibodies against SK-1 (upper panels), SK-2 (middle panels) or β-actin (lower panels). (B–D) Quiescent mouse 
mesangial cells (B) and mouse embryonic fibroblasts (C) isolated from either C57BL/6 mice (Wt) or SK-2 deficient mice (SK-2ko) or tran-
siently transfected mouse mesangial cells with either non-target siRNA (D, NT-siRNA) or siRNA against SK-2 (D, siSK-2) were taken for RNA 
extraction and subjected to quantitative PCR analysis using mouse primers of S1P1-5 (B, C) or S1P3 (D) as described in the Methods section. 
Data were obtained according to the ΔΔCT method and are expressed as fold induction of S1P1 expression level (B, C) or as% of NT-siRNA (D) 
and are mean±SD (n = 3–4). *p < 0.05, **p < 0.01, ***p < 0.001 considered statistically significant compared to the corresponding Wt values. 
(E, F) Lipids were extracted from quiescent mouse mesangial cells (E) and mouse embryonic fibroblasts (F) from wild-type (Wt, white bars) 
and SK-2 deficient mice (SK-2ko, grey bars) and taken for LC-MS/MS to quantify sphingosine 1-phosphate (S1P), sphingosine (Sph) and 
C16-ceramide (C16-Cer). Results are expressed as ng lipid per 106 cells and are mean±SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 considered 
statistically significant compared to the corresponding Wt values.
hyperphosphorylation in breast cancer cells. Such an 
activation of SK-2 by growth factors is hardly consistent 
with a growth inhibiting and pro-apoptotic effect of SK-2. 
In fact, we previously showed that in the breast cancer 
cell line MCF-7, EGF and estrogen rather down-regulated 
SK-2 mRNA expression (Döll et  al., 2005, 2007), which 
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Figure 8: Effect of S1P receptor antagonists on the increased migra-
tion of mouse mesangial cells.
Quiescent wild-type (Wt, white bars) or SK-2 deficient (SK-2ko, 
grey bars) mesangial cells (mMC) were subjected to a scratch and 
then allowed to recover for 24 h in DMEM containing 1% FBS in the 
presence of either vehicle (Ctrl) or VPC23019 (VPC, 10 μm), W146 
(10 μm) or JTE-013 (JTE, 10 μm). Light microscopy pictures were 
taken at time point 0 h and 24 h after the scratch and analyzed 
using the Image J software (Wayne Rasband, NIH, USA) by measur-
ing the scratch area. Data are expressed as area reduction from 
time points 0 h to 24 h as % of the Wt ctrl and are mean±SD (n = 4). 
**p < 0.01, ***p < 0.001 considered statistically significant com-
pared to the Wt ctrl, §§p < 0.01 considered statistically significant 
compared to the SK-2ko ctrl value.
Figure 9: Effect of S1P3 knockout on proliferation and migration of 
mouse mesangial cells.
(A) 105 mesangial cells isolated from either BalbC mice (Wt, empty 
circles) or S1P3-deficient mice (S1P3ko, black circles) were plated and 
grown for the indicated time periods in growth medium supplemented 
with [3H]thymidine and processed as described in the Methods 
section. [3H]thymidine incorporated into DNA was measured in a 
β-counter. Data are expressed as cpm/well and are mean±SD (n = 3). 
*p < 0.05, ***p < 0.001 considered statistically significant compared 
to the corresponding control values. (B) Quiescent control mouse 
mesangial cells (Wt, white bars) or S1P3-deficient mesangial cells 
(S1P3ko, grey bars) were subjected to a scratch and allowed to recover 
for 24 h in DMEM containing 1% FBS the presence of either vehicle 
(Ctrl) or S1P (1 μm). Light microscopy pictures were taken at time point 
0 h and 24 h after the scratch and analyzed using the Image J software 
(Wayne Rasband, NIH, USA) by measuring the scratch area. Data are 
expressed as area reduction from time points 0 h to 24 h as % of the 
Wt ctrl value and are mean±SD (n = 4–6). **p < 0.01 considered statisti-
cally significant compared to the Wt ctrl value. (C) Quiescent mouse 
mesangial cells isolated from either BalbC mice (Wt, white bars) or 
S1P3-deficient mice (S1P3ko, grey bars) were stimulated for 10 min 
with either vehicle (Ctrl) or sphingosine 1-phosphate (S1P, 1 μm) in the 
presence of 1% FBS. Thereafter, cell lysates were subjected to G-LISA® 
RhoA activation assay according to the manufacturer’s instructions. 
Data are expressed as % of Wt ctrl value and are mean±SD (n = 4). 
*p < 0.05, ***p < 0.001 considered statistically significant compared 
to the vehicle treated Wt value, §§§p < 0.001 considered statistically 
significant compared to the S1P stimulated Wt value.
occurred concomitantly to an upregulation of SK-1 by 
these factors.
Recently, a catalytic inhibitor of SK-2 ABC294640 
(French et  al., 2010; Antoon et  al., 2011) was devel-
oped and used to investigate the cellular function of 
SK-2. Although the in vitro IC50 for SK-2 was rather high 
with 50 μm (French et  al., 2010), oral administration of 
ABC294640 to mice bearing mammary adenocarcinoma 
xenografts resulted in a dose-dependent antitumor activ-
ity associated with depletion of S1P levels in the tumors 
and progressive tumor cell apoptosis (French et  al., 
2010; Antoon et al., 2011). These data suggested that SK-2 
similar to SK-1 also drives cancer growth and progression. 
In the present study, treatment of mesangial cells with 30 
and 100 μm ABC294640 decreased proliferation, which, 
however, was also detected in SK-2ko cells (Figure 2C). 
These data clearly demonstrate that ABC294640 elicits 
an anti-proliferative effect independent of SK-2 inhibi-
tion, thereby questioning the specificity of ABC294640. 
Recently, ABC294640 was shown to exert anti-estrogenic 
effects by directly antagonising estrogen receptor (ER) 
activation (Antoon et  al., 2010). Molecular modelling 
studies revealed a direct docking of ABC294640 into the 
ligand binding site of the ERα. This estrogen antagonistic 
potential may explain on the one hand the anti-prolifer-
ative effect and on the other hand why especially estro-
gen-sensitive breast cancer cells were strongly affected 
by the compound. The comparison of in vivo effects of 
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ABC294640 with the effect of genetic SK-2 knockout mice 
also revealed inconsistent results. Whereas the inhibitor 
aggravated inflammatory arthritis, SK-2 knockout mice 
showed no change of disease severity compared to wild-
type mice (Baker et al., 2013). Moreover, Liang et al. (2013) 
showed that SK-2 deficient mice develop more severe 
chronic intestinal inflammation and colitis-associated 
cancer, which, in terms of mechanism, was proposed to 
involve a counter-upregulation of SK-1 and S1P.
Our study also showed a compensatory upregula-
tion of SK-1 protein in SK-2ko cells and SK-2-siRNA trans-
fected cells, although the exact mechanisms leading to 
the observed enhanced SK-1 expression are not known. 
However, using LC-MS/MS we detected a rise of cellu-
lar S1P only in SK-2ko MEF but not in SK-2ko mMCs. The 
reason for this discrepancy might be the result of a detec-
tion limit, as we only measured S1P in whole-cell lipid 
extracts but not in subcellular fractions. Another possibil-
ity is that produced S1P is secreted more efficiently from 
mesangial cells than from fibroblasts. However, so far we 
were not able to measure an increased level in cell culture 
supernatants (data not shown). Further experiments are 
needed to clarify this issue.
In addition, our data revealed that specifically the S1P3 
receptor was upregulated upon loss of SK-2 (Figure 7B–D). 
We therefore speculate that increased proliferation and 
migration observed in SK-2ko cells may be due to this 
enhanced S1P3 expression. We obtained evidence that S1P3 
is involved in mesangial cell migration and proliferation 
from S1P3 knockout mesangial cells as (i) the S1P3ko cells 
showed a slower proliferation rate in comparison to wild-
type cells (Figure 9A) and (ii) S1P was able to induce cell 
migration only in wild-type but not in S1P3ko cells (Figure 
9B). Furthermore, the S1P1/3 antagonist VPC23019, but not 
the S1P1 antagonist W146, reduced migration in mMC. This 
effect was only observed in SK-2ko cells, which showed a 
higher S1P3 mRNA expression, and not in Wt cells (Figure 8). 
However, as mesangial cell proliferation was only partially 
reduced in S1P3-deficient cells and also showed normal 
migration behavior under control conditions, we conclude 
that other receptor subtypes are involved too. Katsuma 
et  al. reported that extracellular S1P triggers mesangial 
cell proliferation by involving both S1P2 and S1P3 (Katsuma 
et al., 2002). Similarly, proliferation of hepatoma cells (An 
et  al., 2000) and satellite cells (Calise et  al., 2012) also 
depended on both S1P2 and S1P3. Concerning cell migra-
tion, we observed an increased migration of mesangial cells 
when inhibiting the S1P2 receptor with JTE013, suggesting a 
potentially inhibitory role of S1P2 in cell migration, which 
was previously also reported in other cell types (Osada 
et al., 2002; Arikawa et al., 2003; Goparaju et al., 2005).
Similar to S1P2, the involvement of S1P3 in a migratory 
event is also conflicting. In this respect, Okamoto et  al. 
(2000) showed that overexpression of S1P1 and S1P3 in 
Chinese hamster ovary (CHO) cells resulted in more S1P-
stimulated migration. A similar situation was reported for 
human endothelial cells where S1P-triggered migration 
was abolished by antisense oligonucleotides against S1P1 
and S1P3 (Paik et al., 2001), and in lung cancer cells where 
either a S1P3 knockdown by RNAi or Rho kinase inhibition 
by a catalytic inhibitor prevented a S1P-stimulated migra-
tory/invasive response (Zhang et al., 2013).
By generating S1P receptor knockout mice, it turned 
out that S1P1 deficiency is embryonically lethal, as vas-
cular maturation failed due to a defect in smooth muscle 
cells migration (Liu et  al., 2000b). Consistently, embry-
onic fibroblasts (MEF) isolated from these S1P1 deficient 
mice also exhibited a defect in chemotaxis towards S1P 
(Liu et al., 2000b). These data clearly support an in vivo 
relevant function of S1P1 in smooth muscle cell and fibro-
blast migration. In contrast, S1P3 deficient mice showed 
no vascular maturation deficit, suggesting that S1P3 is 
not involved in smooth muscle cell migration and conse-
quently vessel maturation (Liu et al., 2000b; Ishii et al., 
2001).
Although these data do not allow a general conclu-
sion, they somehow stress the possibility that S1P3, likely 
in cooperation with S1P1, is involved in S1P-stimulated cell 
migration in a cell-type specific manner.
Our data further demonstrate that not only the basal 
but also the S1P-stimulated RhoA activity is enhanced 
in SK-2 deficient cells. RhoA is one of three members of 
the Rho GTPase family that plays a crucial role in the 
regulation of cell migration. There seems to be a spati-
otemporal dynamic of RhoA action driving not only mem-
brane protrusions at the leading edge of the cells but also 
tail retraction (Pertz et  al., 2006). Although previously 
regarded as an anti-migratory GTPase, the finding that 
RhoA localizes at the leading edge of cells where it is 
important for membrane ruffling and lamellae formation 
confirms other studies describing RhoA as pro-migratory 
factor (for review, see O’Connor and Chen, 2013). As we 
were only able to measure RhoA activity in whole-cell 
lysates, we cannot decipher the exact cellular localiza-
tion of the enhanced RhoA activity in SK-2ko cells to allow 
a final conclusion on the specific impact of RhoA acting 
pro-migratory on the leading edge or anti-migratory by 
tail retraction in mesangial cells. However, RhoA is acti-
vated by extracellular S1P in many cell types including 
CHO cells (Okamoto et al., 2000), endothelial cells (Paik 
et  al., 2001), and bladder cancer cells (vom Dorp et  al., 
2011), and this seems to be mandatory for cell migration. 
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It is tempting to speculate that both S1P2 and S1P3 recep-
tors cooperatively orchestrate cell migration. All these 
data suggest that it is well conceivable that an enhanced 
SK-1/S1P3/RhoA signaling contributes to the increased 
migration of SK-2ko cells.
Notably, in SK-2ko cells there was a much more pro-
nounced increase of sphingosine and C16-ceramide 
compared to S1P (Figures 7E and 7F), supporting specu-
lations whether another sphingolipid mediator besides 
S1P contributes to the effects observed in this study. In 
this regard, we and others have shown that ceramide can 
directly bind to and activate c-Raf (Huwiler et al., 1996), 
PKC-α (Huwiler et al., 1998) and PKC-ζ (Muller et al., 1995) 
but inhibit PKC-δ (Huwiler et al., 1998; Bessa et al., 2013). 
Further studies are needed to evaluate the exact contribu-
tion of the various sphingolipid-derived mediators to the 
observed phenotype of SK-2ko mesangial cells.
Although our study has only addressed the effect 
of SK-2ko in mesangial cells, it will be interesting to see 
whether in vivo in a renal disease model SK-2 deficient 
mice also respond with increased proliferation and migra-
tion. In this context, in a renal ischemia/reperfusion injury 
(IRI) model in SK-2ko mice it was reported that loss of SK-2 
led to more severe kidney injury as indicated by elevated 
plasma creatinine levels, increased tubular cell necro-
sis, dilation of tubules, and cast formation in the outer 
medulla. In addition, kidneys of IRI-exposed SK-2ko mice 
not only showed more neutrophil infiltration but remark-
ably also increased S1P3 expression (Jo et al., 2009), which 
supports our data obtained in renal mesangial cells and 
fibroblasts.
Altogether, our data show for the first time that loss 
of SK-2 in renal mesangial cells and fibroblasts may have 
considerable impact on cell growth and migration, and 
that SK-2 exerts a suppressive effect on these cellular 
responses that are crucial in many renal diseases, such as 
renal cancer and chronic inflammatory kidney diseases.
Materials and methods
Chemicals
[6–3H]methyl-thymidine (specific activity: 14.5 Ci/mmol was from 
American Radiolabeled Chemicals Inc., St. Louis, MO, USA. The 
secondary anti-rabbit and anti-mouse horseradish peroxidase-
coupled antibodies, HyperfilmMP and the enhanced chemilumi-
nescence (ECL) reagents were from GE Health Care Systems GmbH, 
Freiburg, Germany. Sphingolipid standards for LC/MS, W146, JTE-
013 and VPC23019 were from Avanti Polar Lipids Inc., Alabaster, 
AL, USA; U0126, and wortmannin were from Merck Biosciences, 
Schwalbach, Germany. Antibodies against phospho-Ser473-PKB/Akt, 
phospho-ERK1/2, total Akt, and total ERK1/2 were from Cell Signal-
ing, Frankfurt, Germany; the β-actin antibody (clone AC-15), DAPI, 
were from Sigma Aldrich Fine Chemicals, St. Louis, MO, USA. RhoA 
G-lisa was from Cytoskeleton Inc., CO, USA. All cell culture media 
and supplements were from Invitrogen, Allschwil, Switzerland.
Peptide synthesis and antibody generation for SK-1 and 
SK-2 antibodies
Peptide synthesis and antibody generation was performed by Euro-
gentec s.a. (Seraing, Belgium). Two synthetic peptides based on the 
sequence of the mouse SK-1 (accession number: NM_011451) (-CPS 
GRD SRR GPP PEE P-COOH and -LEP RSQ-RGV FSV DGE C-CONH2) or 
on the sequence of the mouse SK-2 (accession number: NM_020011) 
(-CTL LTG PAG QKP QA-COOH and -CPI AEG PPE MPA SSG F-CONH2) 
were synthesized and coupled to keyhole-limpet hemocyamin, and 
used to immunize two rabbits. The antibodies from terminal bleeds 
were purified by affinity chromatography by using an anti-peptide-
coupled sepharose column.
Cell culture
Primary cultures of mouse renal mesangial cells were isolated from 
C57BL/6 mice (Wt) or SK-2 knockout (ko) mice exactly as previously 
described (Klawitter et  al., 2007; Hofmann et  al., 2008). Outgrown 
mesangial cells were subcultured and further used up to passage 
20. Cells were cultured in RPMI medium containing 15% FBS, 10 mm 
HEPES, pH 7.4, 100 units/ml penicillin, 100 μg/ml streptomycin, 
6 μg/ml bovine insulin, 5 μg/ml transferrin, 5 ng/ml sodium selenite, 
4.5 μg/ml β-mercaptoethanol. Mouse embryonic fibroblasts (MEF) 
were isolated from C57BL6 mice or SK-2 deficient mice as previously 
described (Conner, 2001). Cells were cultured in Dulbecco’s modified 
Eagle medium (DMEM) containing 10% FBS, 10 mm HEPES, pH 7.4, 
100 units/ml penicillin, 100 μg/ml streptomycin.
siRNA transfection
siRNA transfection was conducted by using the Amaxa™ Mouse/Rat 
Hepatocyte Nucleofector™ Kit (Lonza, Cologne, Germany) according 
to the Amaxa™ protocol for mouse embryonic fibroblasts. Briefly, 
mouse mesangial cells were harvested by trypsinization, centrifuged 
and resuspended in 100 μl Nucleofector™ solution. After addition 
of either 0.5 μm non-target siRNA (Thermo Fisher Scientic, Waltham, 
MA, USA) or 0.5 μm SK-2 siRNA (antisense sequence: GCC CUA CAC 
AUA CAG CGA C) transfection was performed in a cuvette using proto-
col N-024. The cells were immediately transferred to the culture plate 
and cultured at 37°C for 1–2 days prior to use in further experiments.
Cell stimulation and Western blot analysis
Confluent cells in 100 mm diameter dishes were rendered quiescent 
by incubating for 24 h in DMEM containing 0.1 mg/ml of fatty acid-
free bovine serum albumin (BSA). Thereafter, cells were treated as 
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indicated. To stop the stimulation, the medium was withdrawn and 
cells were homogenized as previously described (Rölz et al., 2002). 
Equal amounts of protein were separated by SDS-PAGE, transferred 
to nitrocellulose membranes, and subjected to Western blot analysis 
as previously described (Rölz et al., 2002).
Transwell migration assay
Cell migration was measured by using an adapted Boyden chamber 
assay. In brief, the ability of cells to migrate through a Transwell filter 
(6.5 mm diameter, 8 μm pore size) was analyzed. After serum starva-
tion, cells were detached by trypsinization and seeded into Transwell 
filters at 1 × 105 cells in 100 μl starvation medium. 500 μl of starvation 
medium were placed in the lower compartment and the cells were left 
to migrate for the indicated time periods. Thereafter, the Transwell 
filters were removed and processed as previously described (Huwiler 
et al., 2006). Migrated cells were determined by counting the DAPI-
stained cells on the filters in five random areas per sample using a 
fluorescence microscope.
Scratch assay for cell migration
Equal number of cells were seeded in growth medium in PS35 and 
cultured for 6 h to allow adherence followed by a starvation period 
in DMEM containing 1% of FBS for 18 h. Thereafter, a ‘scratch’ was 
created on the confluent cell monolayer using a p200 pipet tip and 
the dish was immediately photographed under a phase-contrast 
microscope at specific reference points. A second image was taken 
24  h after previous alignment along the reference points to ensure 
assessment of the same scratch area. The images were analyzed 
using the Image J software (Wayne Rasband, NIH, USA) by measuring 
the scratch area at 0 h and 24 h after incubation. Data are expressed 
as area reduction from time points 0 h to 24 h.
[3H]Thymidine incorporation
5000 cells were plated per well of a 24-well plate and incubated for 
20 h. Thereafter, cells were incubated in growth medium containing 
0.2 μCi/ml of [3H]methyl-thymidine. After different time periods, the 
medium was removed and cells were washed twice with PBS and 
incubated with ice-cold 5% trichloroacetic acid (TCA) for 30 min. 
Cells were washed twice with 5% TCA, the DNA was solubilized in 
1 m NaOH for 30 min at 37°C, and the radioactivity was counted in 
a β-counter.
Quantitative PCR analysis
Real-time PCR was performed using SYBRgreen® and a BioRad iQ 
iCycler Detection System. Primer sequences were as follows. Mouse 
S1P1: forward: CTG ACC TTC CGC AAG AAC ATC T; reverse: CTT CAG 
CAA GGC CAG AGA CTT C; mouse S1P2: forward: GAG CTC ATC ACC 
TCT TCA TCC TAT C; reverse: GAA GAT GCA GTA AGA GTA CCC AGG A; 
mouse S1P3: forward: TGT AGC TTC ATC GTC GTC TTG GAG; reverse: 
GCC GAT GAA AAA GTA CAT GCG G; mouse S1P4: forward: GGC TAC 
TGG CAG CTA TCC TG; reverse: AAG GCC ACC AAG ATC ATC AG; 
mouse S1P5: forward: GGA GGG ACT CTC CTG GAT TC; reverse: TTC 
CTC TGT AGC CAG CCA CT. IQ™5 Optical System Software (Version 
2.0) was used to analyze real-time and endpoint fluorescence. One 
microgram of total RNA isolated with TRIZOL® reagent was used for 
reverse transcriptase-PCR (First Strand Synthesis Kit, MBI Fermen-
tas, St-Leon-Roth, Germany); a random hexamer primer was utilized 
for amplification. The fold induction values were obtained using to 
the ΔΔCT method, after normalization to the housekeeping gene 18S 
RNA.
RhoA activity assay
The activity of the small G protein RhoA was determined by using a 
specific G-LISA™ activity assay kit (Cytoskeleton Inc., Denver, CO, 
US) exactly as described in the manufacturer’s manual.
Lipid quantification by mass spectrometry
Confluent cells in PS35 wells were either taken for lipid extraction 
and LC-MS/MS analysis exactly as previously described (Hofmann 
et al., 2008) or taken for cell counting for lipid equalization.
Statistical analysis
Statistical analysis was performed by unpaired t-test and two-tailed 
p-values for the comparison of two groups, and by one-way analysis 
of variance (ANOVA) with Bonferroni post-test for the comparison of 
three and more groups.
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